LG Life Sciences (XKRX:068875.PFD) Debt-to-Asset : 0.43 (As of Sep. 2016)

View and export this data going back to 2002. Start your Free Trial

What is LG Life Sciences Debt-to-Asset?

LG Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2016 was ₩142,524.24 Mil. LG Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2016 was ₩223,189.04 Mil. LG Life Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2016 was ₩844,538.88 Mil. LG Life Sciences's debt to asset for the quarter that ended in Sep. 2016 was 0.43.

LG Life Sciences Debt-to-Asset Historical Data

The historical data trend for LG Life Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LG Life Sciences Debt-to-Asset Chart

LG Life Sciences Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Debt-to-Asset

Get a 7-Day Free Trial

0.33

0.35

0.41

0.48

0.45

LG Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Debt-to-Asset	Get a 7-Day Free Trial															0.46	0.45	0.46	0.45	0.43

Competitive Comparison of LG Life Sciences's Debt-to-Asset

For the Biotechnology subindustry, LG Life Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LG Life Sciences's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LG Life Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where LG Life Sciences's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

LG Life Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

LG Life Sciences's Debt-to-Asset for the fiscal year that ended in Dec. 2015 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(60212.252	+	259538.207)	/	703705.604
	=	0.45

LG Life Sciences's Debt-to-Asset for the quarter that ended in Sep. 2016 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(142524.244	+	223189.039)	/	844538.884
	=	0.43

LG Life Sciences (XKRX:068875.PFD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

LG Life Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of LG Life Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

LG Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LG Life Sciences Ltd (XKRX:068875.PFD) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lgls.com

LG Life Sciences., Ltd. manufactures and markets medicines and fine chemistry products. The company produces the medicine based on genetic engineering and raw materials for agricultural pesticides and medicines.

LG Life Sciences Headlines

No Headlines